April 25 (Reuters) - Merck KGaA MRCG.DE:
EQS-ADHOC: MERCK KGAA: MERCK CONFIRMS LATE-STAGE DISCUSSIONS WITH SPRINGWORKS THERAPEUTICS, INC. ON POTENTIAL ACQUISITION
MERCK KGAA: PARTIES ARE IN DISCUSSION ON BASIS OF A PRICE OF AROUND USD 47 PER SHARE
MERCK KGAA: NO FINAL DECISION HAS BEEN TAKEN AND NO LEGALLY BINDING AGREEMENT HAS BEEN ENTERED INTO
Source text: ID:nEQ3NsrHga
Further company coverage: MRCG.DE
((reuters.briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.